Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.
Inflammatory bowel disease is a chronic gastrointestinal inflammatory disorder associated with changes in neuropeptide expression and function, including vasoactive intestinal peptide (VIP). VIP regulates intestinal vasomotor and secretomotor function and motility; however, VIP's role in develo...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4416880?pdf=render |
| _version_ | 1818822817352777728 |
|---|---|
| author | Xiujuan Wu Victoria S Conlin Vijay Morampudi Natasha R Ryz Yasmin Nasser Ganive Bhinder Kirk S Bergstrom Hong B Yu Chris C M Waterhouse Allison M J Buchan Oana E Popescu William T Gibson James A Waschek Bruce A Vallance Kevan Jacobson |
| author_facet | Xiujuan Wu Victoria S Conlin Vijay Morampudi Natasha R Ryz Yasmin Nasser Ganive Bhinder Kirk S Bergstrom Hong B Yu Chris C M Waterhouse Allison M J Buchan Oana E Popescu William T Gibson James A Waschek Bruce A Vallance Kevan Jacobson |
| author_sort | Xiujuan Wu |
| collection | DOAJ |
| description | Inflammatory bowel disease is a chronic gastrointestinal inflammatory disorder associated with changes in neuropeptide expression and function, including vasoactive intestinal peptide (VIP). VIP regulates intestinal vasomotor and secretomotor function and motility; however, VIP's role in development and maintenance of colonic epithelial barrier homeostasis is unclear. Using VIP deficient (VIPKO) mice, we investigated VIP's role in epithelial barrier homeostasis, and susceptibility to colitis. Colonic crypt morphology and epithelial barrier homeostasis were assessed in wildtype (WT) and VIPKO mice, at baseline. Colitic responses were evaluated following dinitrobenzene sulfonic acid (DNBS) or dextran-sodium sulfate (DSS) exposure. Mice were also treated with exogenous VIP. At baseline, VIPKO mice exhibited distorted colonic crypts, defects in epithelial cell proliferation and migration, increased apoptosis, and altered permeability. VIPKO mice also displayed reduced goblet cell numbers, and reduced expression of secreted goblet cell factors mucin 2 and trefoil factor 3. These changes were associated with reduced expression of caudal type homeobox 2 (Cdx2), a master regulator of intestinal function and homeostasis. DNBS and DSS-induced colitis were more severe in VIPKO than WT mice. VIP treatment rescued the phenotype, protecting VIPKO mice against DSS colitis, with results comparable to WT mice. In conclusion, VIP plays a crucial role in the development and maintenance of colonic epithelial barrier integrity under physiological conditions and promotes epithelial repair and homeostasis during colitis. |
| first_indexed | 2024-12-18T23:30:06Z |
| format | Article |
| id | doaj.art-b42e8ac2ad284d81ba5df0a8993f38c6 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-18T23:30:06Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-b42e8ac2ad284d81ba5df0a8993f38c62022-12-21T20:47:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01105e012522510.1371/journal.pone.0125225Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice.Xiujuan WuVictoria S ConlinVijay MorampudiNatasha R RyzYasmin NasserGanive BhinderKirk S BergstromHong B YuChris C M WaterhouseAllison M J BuchanOana E PopescuWilliam T GibsonJames A WaschekBruce A VallanceKevan JacobsonInflammatory bowel disease is a chronic gastrointestinal inflammatory disorder associated with changes in neuropeptide expression and function, including vasoactive intestinal peptide (VIP). VIP regulates intestinal vasomotor and secretomotor function and motility; however, VIP's role in development and maintenance of colonic epithelial barrier homeostasis is unclear. Using VIP deficient (VIPKO) mice, we investigated VIP's role in epithelial barrier homeostasis, and susceptibility to colitis. Colonic crypt morphology and epithelial barrier homeostasis were assessed in wildtype (WT) and VIPKO mice, at baseline. Colitic responses were evaluated following dinitrobenzene sulfonic acid (DNBS) or dextran-sodium sulfate (DSS) exposure. Mice were also treated with exogenous VIP. At baseline, VIPKO mice exhibited distorted colonic crypts, defects in epithelial cell proliferation and migration, increased apoptosis, and altered permeability. VIPKO mice also displayed reduced goblet cell numbers, and reduced expression of secreted goblet cell factors mucin 2 and trefoil factor 3. These changes were associated with reduced expression of caudal type homeobox 2 (Cdx2), a master regulator of intestinal function and homeostasis. DNBS and DSS-induced colitis were more severe in VIPKO than WT mice. VIP treatment rescued the phenotype, protecting VIPKO mice against DSS colitis, with results comparable to WT mice. In conclusion, VIP plays a crucial role in the development and maintenance of colonic epithelial barrier integrity under physiological conditions and promotes epithelial repair and homeostasis during colitis.http://europepmc.org/articles/PMC4416880?pdf=render |
| spellingShingle | Xiujuan Wu Victoria S Conlin Vijay Morampudi Natasha R Ryz Yasmin Nasser Ganive Bhinder Kirk S Bergstrom Hong B Yu Chris C M Waterhouse Allison M J Buchan Oana E Popescu William T Gibson James A Waschek Bruce A Vallance Kevan Jacobson Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice. PLoS ONE |
| title | Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice. |
| title_full | Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice. |
| title_fullStr | Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice. |
| title_full_unstemmed | Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice. |
| title_short | Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice. |
| title_sort | vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice |
| url | http://europepmc.org/articles/PMC4416880?pdf=render |
| work_keys_str_mv | AT xiujuanwu vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT victoriasconlin vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT vijaymorampudi vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT natasharryz vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT yasminnasser vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT ganivebhinder vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT kirksbergstrom vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT hongbyu vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT chriscmwaterhouse vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT allisonmjbuchan vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT oanaepopescu vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT williamtgibson vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT jamesawaschek vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT bruceavallance vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice AT kevanjacobson vasoactiveintestinalpolypeptidepromotesintestinalbarrierhomeostasisandprotectionagainstcolitisinmice |